295 related articles for article (PubMed ID: 36678862)
1. Translational Considerations in the Development of Intranasal Treatments for Epilepsy.
Prentice RN; Rizwan SB
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678862
[TBL] [Abstract][Full Text] [Related]
2. A review of intranasal formulations for the treatment of seizure emergencies.
Kapoor M; Cloyd JC; Siegel RA
J Control Release; 2016 Sep; 237():147-59. PubMed ID: 27397490
[TBL] [Abstract][Full Text] [Related]
3. The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters.
Chung S; Peters JM; Detyniecki K; Tatum W; Rabinowicz AL; Carrazana E
Epilepsy Behav Rep; 2023; 21():100581. PubMed ID: 36636458
[TBL] [Abstract][Full Text] [Related]
4. Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview.
Musumeci T; Bonaccorso A; Puglisi G
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30871237
[TBL] [Abstract][Full Text] [Related]
5. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
6. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery.
Shringarpure M; Gharat S; Momin M; Omri A
Expert Opin Drug Deliv; 2021 Feb; 18(2):169-185. PubMed ID: 32921169
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and physiological considerations for efficient nose-to-brain targeting.
Bahadur S; Pathak K
Expert Opin Drug Deliv; 2012 Jan; 9(1):19-31. PubMed ID: 22171740
[TBL] [Abstract][Full Text] [Related]
8. Formulation considerations for improving intranasal delivery of CNS acting therapeutics.
Patel D; Thakkar H
Ther Deliv; 2022 Jul; 13(7):371-381. PubMed ID: 36416617
[TBL] [Abstract][Full Text] [Related]
9. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
[TBL] [Abstract][Full Text] [Related]
10. Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
Keller LA; Merkel O; Popp A
Drug Deliv Transl Res; 2022 Apr; 12(4):735-757. PubMed ID: 33491126
[TBL] [Abstract][Full Text] [Related]
11. Insights into direct nose to brain delivery: current status and future perspective.
Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain delivery of levetiracetam after intranasal administration to mice.
Gonçalves J; Bicker J; Gouveia F; Liberal J; Oliveira RC; Alves G; Falcão A; Fortuna A
Int J Pharm; 2019 Jun; 564():329-339. PubMed ID: 31015006
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A Novel Approach to Diagnosis and Treatment.
Khan J; Yadav S
Pharm Nanotechnol; 2023 Oct; ():. PubMed ID: 37818558
[TBL] [Abstract][Full Text] [Related]
14. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery.
Nguyen TT; Maeng HJ
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335948
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Intranasal Drug Delivery with Intravail
Rabinowicz AL; Carrazana E; Maggio ET
Drugs R D; 2021 Dec; 21(4):361-369. PubMed ID: 34435339
[TBL] [Abstract][Full Text] [Related]
17. Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs.
Lofts A; Abu-Hijleh F; Rigg N; Mishra RK; Hoare T
CNS Drugs; 2022 Jul; 36(7):739-770. PubMed ID: 35759210
[TBL] [Abstract][Full Text] [Related]
18. Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration.
Gonçalves J; Alves G; Carona A; Bicker J; Vitorino C; Falcão A; Fortuna A
Pharm Res; 2020 Mar; 37(4):74. PubMed ID: 32215749
[TBL] [Abstract][Full Text] [Related]
19. Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives.
Hong SS; Oh KT; Choi HG; Lim SJ
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31627301
[TBL] [Abstract][Full Text] [Related]
20. Unravelling Micro and Nano vesicular System in Intranasal Drug Delivery for Epilepsy.
Salave S; Rana D; Pardhe R; Bule P; Benival D
Pharm Nanotechnol; 2022 Apr; ():. PubMed ID: 35473543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
